These findings collectively underscore the pivotal role for LINC00960 in TNBC and its significant implications in breast cancer prognosis, further underscoring its potential as a valuable prognostic biomarker and therapeutic target in the clinical management of this aggressive subtype. This evidence concerns the gene LINC00960 and breast cancer.